About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aardvark Therapeutics, Inc. - Common Stock (NQ:AARD)

1.305 +0.225 (+20.83%)
Delayed Quote Updated: 2:48 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Aardvark Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >
Unusual Volume in Small-Cap US Stocks: Mixed Session of Gains and Sharp Losses ↗
Via Chartmill
After-Hours Movers: Oct. 23 Postmarket Gainers and Losers ↗
Via Chartmill
Top US Stock Gainers and Losers in Today's Session ↗
Via Chartmill
Today's U.S. Session Top Movers: Small-Cap Gainers and Losers ↗
Via Chartmill
Gap-Up and Gap-Down Stocks: October 23, 2026 Session ↗
Via Chartmill
Postmarket Movers: After-Hours Gainers and Decliners ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's after-market session. The market value of their outstanding shares is at $144.8 million. TransCode... 
Via Benzinga
Unusual volume stocks in Monday's session ↗
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-07-10: top gainers and losers in today's session. ↗
Via Chartmill
Here are the top movers in Friday's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
Monday's session: top gainers and losers ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗
Aardvark Therapeutics shares saw brokerage downgrades after the company paused its Phase 3 trial to treat hyperphagia in patients with Prader-Willi syndrome. 
Via Stocktwits
Get insights into the top gainers and losers of Monday's pre-market session. ↗
Via Chartmill
News headline image
Aardvark Therapeutics Becomes Next Pharma Player To Quit Prader-Willi Syndrome Drug Development Efforts ↗
The company said that the decision was based on certain cardiac observations made during routine safety monitoring in a healthy volunteer study. 
Via Stocktwits
Top movers in Friday's after hours session ↗
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
These stocks are moving in today's session ↗
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Which stocks are gapping on Wednesday? ↗
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Which stocks are moving after the closing bell on Tuesday? ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
This Aardvark Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday ↗
 
Via Benzinga
News headline image
This Coinbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Aardvark Therapeutics Reports Q2 Loss ↗
Via The Motley Fool
News headline image
Aardvark's Hunger-Suppressing Drug Promises Weight Loss Without GI Distress ↗
Aardvark's lead drug ARD-101 targets PWS and HO with trials underway and funding secured through 2027 after a $94.2 million IPO in February. 
Via Benzinga
Topics Initial Public Offering
News headline image
These stocks are gapping in today's session ↗
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.